Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Fennec Pharmaceuticals (FENC) Non Operating Investment Income: 2011-2014

Historic Non Operating Investment Income for Fennec Pharmaceuticals (FENC) over the last 4 years, with Sep 2014 value amounting to $379,000.

  • Fennec Pharmaceuticals' Non Operating Investment Income rose 122.19% to $379,000 in Q3 2014 from the same period last year, while for Sep 2014 it was $4.9 million, marking a year-over-year decrease of 10.38%. This contributed to the annual value of $349,000 for FY2014, which is N/A change from last year.
  • Per Fennec Pharmaceuticals' latest filing, its Non Operating Investment Income stood at $379,000 for Q3 2014, which was up 109.39% from $181,000 recorded in Q2 2014.
  • In the past 5 years, Fennec Pharmaceuticals' Non Operating Investment Income ranged from a high of $7.5 million in Q2 2013 and a low of -$3.6 million during Q1 2013.
  • Over the past 3 years, Fennec Pharmaceuticals' median Non Operating Investment Income value was $379,000 (recorded in 2014), while the average stood at $1.3 million.
  • Within the past 5 years, the most significant YoY rise in Fennec Pharmaceuticals' Non Operating Investment Income was 1,068.22% (2013), while the steepest drop was 1,128.78% (2013).
  • Over the past 4 years, Fennec Pharmaceuticals' Non Operating Investment Income (Quarterly) stood at $4.4 million in 2011, then decreased by 25.77% to $3.3 million in 2012, then skyrocketed by 115.97% to $7.0 million in 2013, then spiked by 122.19% to $379,000 in 2014.
  • Its Non Operating Investment Income was $379,000 in Q3 2014, compared to $181,000 in Q2 2014 and -$2.7 million in Q1 2014.